Clinical Trials Logo

Popliteal Artery Disease clinical trials

View clinical trials related to Popliteal Artery Disease.

Filter by:
  • None
  • Page 1

NCT ID: NCT04546477 Active, not recruiting - Clinical trials for Superficial Femoral Artery Disease

Prospective Multicenter Study to Confirm the Performance of the Renzan Stent in Treatment of SFA/POP Artery Disease

PRIZER
Start date: July 30, 2020
Phase: N/A
Study type: Interventional

The primary objective of this study is to confirm the safety and efficacy of the RenzanTM Peripheral Stent System when used for treatment of superficial femoral (SFA) and/or popliteal (POP) artery disease. This trial plans to include 135 patients in (up to) 10 locations around in Europe.

NCT ID: NCT02698345 Recruiting - Clinical trials for Popliteal Artery Disease

Korean Multicenter Prospective Registry of In.PACT DEB for Isolated Popliteal Artery Disease (K-POP Study)

Start date: January 2016
Phase:
Study type: Observational

- Prospective, multi-center, single-arm registry study - A total of 100 subjects with isolated popliteal artery lesions according to inclusion and exclusion criteria will be enrolled. - All popliteal artery lesions will be treated with drug-eluting balloon (In.PACT Admiral, Medtronic). • Atherectomy or use of bare nitinol stent in combination with drug-eluting balloon is allowed • Patients will be followed clinically for 12 months after the procedure. - Imaging study (Duplex ultrasound, CT angiography or catheter angiography) follow-up will be performed at 12 months.